MOH Molina Healthcare Inc Common Stock
NYSE · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Tem 23, 2026MOH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
MOH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 23 Mayıs 2011 | 3-for-2 | İleri |
Molina Healthcare Inc Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.
History
Molina Healthcare was founded in 1980 by C. David Molina, an emergency room physician in Long Beach, California. He had seen an influx of patients using the emergency room for common illnesses such as a sore throat or the flu because they were being turned away by doctors who would not accept Medi-Cal. Molina established his first primary care clinic with the goal of treating the lowest-income patients, regardless of their ability to pay.
Leadership
For twenty years, the company was run by Dr. Molina's son, J. Mario Molina, MD, a physician. He was the president and CEO of the company. John Molina, Mario's younger brother, was the CFO of Molina Healthcare. The two took over Molina's operations after their father died in 1996 and continued to expand the company. In May 2017 Dr. J. Mario Molina and John Molina were removed from their positions by the Board of Directors, who cited poor financial performance as the reason for the change in leadership. Though the board also discused their displeasure in the CEO and CFO criticising President Donald Trump.[3][4] In October 2017 the company announced Joseph Zubretsky, the former CFO of Aetna, as Molina Healthcare's president and CEO.
Clinics
The first Molina Medical clinic was opened in Wilmington, California in 1980. The company formerly operated clinics in Washington, New Mexico, Florida and Utah. The clinics were opened to provide health care to low-income families and individuals. In August 2017 Molina Healthcare announced it would close several clinics in Michigan, Florida, New Mexico, Wisconsin, and Utah.
Becoming HMO
Molina Healthcare has focused on government-paid healthcare programs such as SCHIP and Medicaid since it became a health maintenance organization in 1985. From 1985 to 1997, the company was based solely in California.
Expansion of health plans
1997: Molina Healthcare acquires Health Reach Family Health Care and enters the states of Utah and Michigan.
2000: Molina Healthcare enters the state of Washington.
2004: Molina Healthcare enters the state of New Mexico.
2005: Molina Healthcare becomes a health plan in Ohio.
2006: Molina Healthcare enters the state of Texas.
2007: Molina Healthcare enters Missouri.
2008: Molina Healthcare enters Florida.
2010: Molina Healthcare enters Wisconsin.
2012: Molina Healthcare enters Illinois.
2013: Molina Healthcare enters South Carolina by acquiring assets from Community Health Solutions.
2013: Molina Healthcare acquires New Mexico Lovelace Medicaid contract.
2014: Molina Healthcare acquires Florida Medicaid assets from First Coast Advantage.
2015: Molina Healthcare enters Chicago market, acquiring MyCare Chicago's Medicaid assets.
2015: Molina Healthcare enters Puerto Rico.
2015: Molina Healthcare of Washington is the first health care company in the state to cover "Virtual Urgent Care" services.
2015: Molina Healthcare acquires Medicaid assets of Integral Health Plan, Inc. in Florida.
2015: Molina Healthcare acquires Providence Human Services and Community Services from Providence Service Corporation and renames them Pathways.
2015: Molina Healthcare adds online access to behavioral health.
2015: Molina Healthcare acquires HealthPlus MIChild and Medicaid programs of Michigan.
2015: Molina Healthcare acquires assets of Loyola Physician Partners' Medicaid Program of Illinois.
2017: Molina Healthcare exits the individual Marketplace in Utah and Wisconsin.
2018: Molina Healthcare loses Medicaid contract with the state of New Mexico.
2018: Molina Healthcare sells Pathways to Altar Capital
2019: Molina Healthcare loses Medicaid contract with the state of Texas.
2020: Molina Healthcare acquires Passport Health Plan in Kentucky.
2021: Molina Healthcare acquires Magellan Complete Care line of business from Magellan Health, Inc. With this acquisition, Molina enters Arizona, Massachusetts, and Virginia.
2021: Molina Healthcare acquires Affinity Health Plan in New York.
2021: Molina Healthcare acquires Cigna's Medicaid contracts in Texas.
2023: Molina Healthcare enters Iowa.
2023: Molina Healthcare loses Medicad contract with the state of Indiana.
2024: Molina Healthcare loses Medicaid contracts with the states of Virginia and Florida.
Going public
Molina Healthcare filed with the Securities and Exchange Commission for an initial stock offering in December 2002 and went public in July 2003 with a stock offering of $102 million. The shares were priced at $17.50, and Molina raised approximately $124 million in the initial public offering. In its stock market debut, Molina sold 6.6 million shares at $20.30, making the company the third-best first day gainer of 2003. Molina Healthcare was the first company from Inc. Magazine's "Inner City 100" list to go public.
Entering the Medicare market
Molina Healthcare entered the Medicare market in 2006. The company currently offers Medicare health plan options in: Arizona, California, Florida, Idaho, Illinois, Kentucky, Massachusetts, Michigan, Nevada, New Mexico, New York, Ohio, South Carolina, Texas, Utah, Virginia, Washington and Wisconsin.
Entering MMIS market
Molina Healthcare acquired Unisys' health information management business in December 2010 to create Molina Medicaid Solutions (MMS). MMS has Medicaid Management Information Systems (MMIS) contracts with Idaho, Louisiana, Maine, New Jersey, West Virginia and the U.S. Virgin Islands. In Autumn 2018, Molina Healthcare, Inc. sold its Medicaid management information systems business, Molina Medicaid Solutions (MMS), to DXC Technology. MMS was a wholly owned subsidiary of Molina Healthcare at the time of sale.
Entering health insurance marketplace
In 2014, Molina Healthcare began offering Marketplace plans in nine states where it offered Medicaid health plans through State Facilitated Marketplaces and Federally Facilitated Marketplace. On November 16, 2016 the Seattle Times reported that about 11 million people currently get their coverage through the exchange. In August 2017 Molina announced it would stop offering plans on the health insurance marketplaces in Utah, Wisconsin, and Maine in 2018.
Dual eligible demonstration projects
Molina was selected to participate in dual eligible demonstration projects in California, Ohio, Illinois, Michigan, South Carolina and Texas to serve patients who are eligible for both Medicare and Medicaid.
Criticism and controversies
A 2023 report investigating "High Rates of Prior
Authorization Denials" reported that Molina Healthcare's Medicaid plans for financially vulnerable people had some of the highest denial percentages in the country. It was reported, that Molina Healthcare operated plans that denied medical care under requests for prior authorization of services in more than 25% of cases in 2019. About 2.7 million people were enrolled in these plans at the time, while another 8.4 million people were enrolled in plans with denial rates higher than average at 15-25%. Some plans had even higher denial rates, as their Illinois plan 41% of requests.
Philanthropy
In May 2022, MolinaCares presented a $100,000 grant to support Compass Health's Broadway Campus Redevelopment Project. The grant will aid funding of construction of a 72,000 square-foot, state-of-the-art facility that will expand community-based behavioural health care services and its workforce in northwest Washington.
In August 2026, MolinaCares awarded a grant of $150,000 to literacy non-profit Indy Reads, to launch a new program in health literacy, in partnership with Molina Healthcare.
Awards and recognition
Molina Healthcare was awarded the 2011 Alfred P. Sloan Award for Business Excellence in Workplace Flexibility. The award ranked Molina Healthcare in the top 20 percent of employers nationally in terms of its programs, policies and culture for creating an effective and flexible workplace. In 2006, Molina Healthcare was named among the 100 best corporate citizens by Business Ethics magazine. In 2005, Time magazine recognized Dr. J. Mario Molina, then CEO of Molina Healthcare, as one of the 25 most influential Hispanics in America.
The company ranked 155th on the 2021 Fortune 500 list of the largest United States corporations by revenue. The company ranked 126th on the 2023 Fortune 500 list of the largest United States corporations by revenue.
Other awards and recognition
2014: Milwaukee Journal Sentinel Recognizes Molina Healthcare of Wisconsin with a Top Workplace Award 2014
2014: Molina Healthcare of New Mexico voted Best Places to Work by Albuquerque Business First
2014: Molina Healthcare was one of 26 companies to participate in President Obama's SupplierPay 2014
2015: Molina Healthcare voted Top Ten Least Stressful Companies to Work for In America 2015
2015: Molina Healthcare ranked 301 in top Fortune 500 2015
2016: Molina Healthcare ranked 201 in top Fortune 500 2016
2017: Molina Healthcare ranked 156 in Fortune 500 2017
2023: Molina Healthcare of Kentucky awarded One of Kentucky's Best Places to Work
2023: Molina Healthcare recognized as one of America's Best-in-State Employers by Forbes
2023: Molina Healthcare recognized as one of Time's World's Best Companies of 2023
2023: Molina Healthcare recognized as one of Newsweek's Greatest Workplaces for Parents and Families 2023
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | MOH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 1053.05Y ort. ≈21.1 | ≈21.1 | 36.3 | Aşırı değerli | |
| F/S (TTM) | 0.25Y ort. ≈0.5 | ≈0.5 | 0.7 | Düşük değerli | |
| F/D (MRQ) | 2.45Y ort. ≈4.3 | ≈4.3 | 3.9 | Düşük değerli | |
| EV / EBITDA (TTM) | 12.75Y ort. ≈7.0 | ≈7.0 | 16.1 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | 36.45Y ort. ≈14.4 | ≈14.4 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 27.05Y ort. ≈11.5 | ≈11.5 | · | · | |
| EV / Gelir (TTM) | 0.15Y ort. ≈0.3 | ≈0.3 | · | · | |
| EV / FCF (TTM) | 17.45Y ort. ≈10.3 | ≈10.3 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 5.35Y ort. ≈7.7 | ≈7.7 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | MOH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | 0.46%5Y ort. ≈3.6% | ≈3.6% | 3.5% | Zayıf | |
| FAVÖK Marjı (TTM) | 0.83%5Y ort. ≈4.1% | ≈4.1% | 3.7% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -0.01%5Y ort. ≈3.2% | ≈3.2% | 2.8% | Zayıf | |
| Net Kâr Marjı (TTM) | -0.02%5Y ort. ≈2.4% | ≈2.4% | 2.9% | Zayıf | |
| ROA (TTM) | -0.04%5Y ort. ≈6.3% | ≈6.3% | 3.0% | Aynı seviyede | |
| ROE (TTM) | -0.16%5Y ort. ≈23.1% | ≈23.1% | 10.1% | Aynı seviyede | |
| ROIC | 8.0%5Y ort. ≈15.3% | ≈15.3% | 8.0% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | MOH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.95Y ort. ≈0.7 | ≈0.7 | 0.7 | Yüksek borç | |
| Cari Oran (MRQ) | 1.75Y ort. ≈1.5 | ≈1.5 | 1.7 | Aynı seviyede | |
| Cari Oran (MRQ) | 1.65Y ort. ≈1.5 | ≈1.5 | 1.3 | Güçlü likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 0.95Y ort. ≈0.7 | ≈0.7 | 0.7 | Yüksek borç |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | MOH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 11.8%5Y ort. ≈19.1% | ≈19.1% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 12.4%5Y ort. ≈15.5% | ≈15.5% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 18.5% | · | · | · | |
| EPS YoY (EPS YB) | -56.3%5Y ort. ≈2.3% | ≈2.3% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | -60.0%5Y ort. ≈0.79% | ≈0.79% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | -13.0%5Y ort. ≈9.2% | ≈9.2% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | -4.5% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | -15.8%5Y ort. ≈7.7% | ≈7.7% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | -6.9% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | MOH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 2.95Y ort. ≈2.6 | ≈2.6 | 2.4 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 13.35Y ort. ≈13.5 | ≈13.5 | 16.3 | Ortalamanın altında | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$2.4M | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Tem 21, 2026 | $1.51 | $1.40 | 7.5% |
| 31 Mart 2026 | $2.35 | $1.94 | 21.0% | |
| 31 Aralık 2025 | $-2.75 | $0.34 | -916.0% | |
| 30 Eylül 2025 | $1.84 | $3.94 | -53.3% | |
| 30 Haziran 2025 | $5.48 | $5.85 | -6.3% | |
| 31 Mart 2025 | $6.08 | $6.02 | 1.1% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Cost of Revenue | $39.49B | $34.43B | $28.67B | $27.18B | $23.70B | $15.82B | $13.90B | · | · | · | · | · | |
| Gross Profit | · | · | · | · | · | $2.48B | $2.30B | $2.52B | $1.81B | $1.73B | $1.53B | $1.00B | |
| SG&A Expense | $3.01B | $2.74B | $2.46B | $2.31B | $2.07B | $1.48B | $1.30B | $1.33B | $1.59B | $1.39B | $1.15B | $765M | |
| Operating Expenses | $44.65B | $38.94B | $32.50B | $30.80B | $26.75B | $18.34B | $15.79B | $17.76B | $20.44B | $17.48B | $13.79B | $9.47B | |
| Operating Income | $781M | $1.71B | $1.57B | $1.17B | $1.02B | $1.08B | $1.04B | $1.13B | $-555M | $306M | $387M | $193M | |
| Interest Expense | · | · | $109M | $110M | $120M | $102M | $87M | $115M | $118M | $101M | $66M | $57M | |
| Interest Income | · | · | · | $75M | $77M | $17M | $17M | $125M | $70M | $38M | $23M | $20M | |
| Other Non-op | · | · | $0 | $0 | $-25M | $-15M | $15M | $-17M | $61M | $0 | $1M | $-1M | |
| Pretax Income | $589M | $1.59B | $1.46B | $1.06B | $875M | $961M | $972M | $999M | $-612M | $205M | $322M | $135M | |
| Income Tax | $117M | $410M | $373M | $271M | $216M | $288M | $235M | $292M | $-100M | $153M | $179M | $73M | |
| Net Income | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| EPS (Basic) | $8.93 | $20.52 | $18.91 | $13.72 | $11.40 | $11.40 | $11.85 | $11.57 | $-9.07 | $0.93 | $2.75 | $1.33 | |
| EPS (Diluted) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 | |
| Shares (Basic) | 52,800,000 | 57,400,000 | 57,700,000 | 57,800,000 | 57,800,000 | 59,000,000 | 62,200,000 | 61,000,000 | 56,000,000 | 55,400,000 | 52,000,000 | 47,000,000 | |
| Shares (Diluted) | 52,900,000 | 57,700,000 | 58,100,000 | 58,500,000 | 58,600,000 | 59,900,000 | 64,200,000 | 67,000,000 | 56,000,000 | 56,000,000 | 56,000,000 | 48,000,000 | |
| EBITDA | $976M | $1.89B | $1.74B | $1.35B | $1.15B | $1.17B | $1.13B | $1.26B | $-377M | $488M | $513M | $327M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.25B | $4.66B | $4.85B | $4.01B | $4.44B | $4.15B | $2.45B | $2.83B | $3.19B | $2.82B | $2.33B | $1.54B | |
| Short-term Investments | $4.01B | $4.33B | $4.26B | $3.50B | $3.20B | $1.88B | $1.95B | $1.68B | $2.52B | $1.76B | $1.80B | $1.02B | |
| Receivables | $3.53B | $3.30B | $3.10B | $2.30B | $2.18B | $1.67B | $1.41B | $1.33B | $871M | $974M | $597M | $596M | |
| Prepaid Expense | $655M | $487M | $331M | $277M | $247M | $175M | $163M | $149M | $239M | $131M | $192M | $49M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $51M | |
| Current Assets | $12.44B | $12.77B | $12.54B | $10.08B | $10.06B | $7.88B | $5.97B | $6.46B | $7.51B | $5.99B | $5.31B | $3.20B | |
| PP&E (Net) | · | · | · | · | · | · | · | $241M | $342M | $454M | $393M | $341M | |
| PP&E (Gross) | $1.11B | $1.03B | $932M | $882M | $822M | $752M | $687M | $774M | $883M | $919M | $755M | $618M | |
| Accum. Depreciation | $875M | $806M | $729M | $695M | $632M | $577M | $530M | $533M | $541M | $465M | $362M | $277M | |
| Goodwill | $1.96B | $1.67B | $1.24B | $1.11B | $982M | $692M | $143M | $143M | $186M | $620M | $519M | $272M | |
| Intangibles | $237M | $267M | $208M | $275M | $270M | $249M | $29M | $47M | $69M | $140M | $122M | $89M | |
| Other Non-current Assets | $147M | $138M | $143M | $123M | $179M | $119M | $105M | $24M | $141M | $41M | $28M | $30M | |
| Total Assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Accounts Payable | $1.09B | $1.33B | $1.25B | $889M | $842M | $641M | $502M | $390M | $366M | $385M | $362M | $242M | |
| Current Liabilities | $7.37B | $7.90B | $8.17B | $6.86B | $7.05B | $4.96B | $3.27B | $4.25B | $5.56B | $4.57B | $3.82B | $2.17B | |
| Capital Leases | $56M | $68M | $85M | $77M | $99M | $42M | $48M | $197M | $198M | $198M | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $0 | $15M | $0 | $24M | |
| Other Non-current Liabilities | $173M | $120M | $124M | $104M | $140M | $119M | $90M | $44M | $61M | $42M | $37M | $34M | |
| Total Liabilities | $11.49B | $11.13B | $10.68B | $9.35B | $9.58B | $7.44B | $4.83B | $5.51B | $7.13B | $5.80B | $5.02B | $3.42B | |
| Long-term Debt | · | · | · | · | · | $2.13B | $1.25B | · | · | $1.65B | $1.41B | $690M | |
| Total Debt | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B | $2.13B | $1.24B | $1.02B | $1.32B | $1.65B | $449M | $341.0K | |
| Retained Earnings | $3.60B | $4.09B | $3.89B | $2.80B | $2.40B | $1.86B | $1.78B | $1.01B | $298M | $810M | $758M | $615M | |
| AOCI | $15M | $-57M | $-82M | $-160M | $-5M | $37M | $4M | $-8M | $-5M | $-2M | $-4M | $-1M | |
| Stockholders' Equity | $4.07B | $4.50B | $4.21B | $2.96B | $2.63B | $2.10B | $1.96B | $1.65B | $1.34B | $1.65B | $1.56B | $1.01B | |
| Liabilities + Equity | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Shares Outstanding | 51,000,000 | 56,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 59,000,000 | 62,000,000 | 62,000,000 | 60,000,000 | 57,000,000 | 56,000,000 | 50,000,000 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $195M | $186M | $171M | $176M | $131M | $88M | $89M | $127M | $178M | $182M | $126M | $134M | |
| Stock-based Comp | $47M | $116M | $115M | $103M | $72M | $57M | $39M | $27M | $46M | $26M | $23M | $22M | |
| Deferred Tax | $43M | $53M | $-31M | $-66M | $-24M | $-19M | $10M | $-6M | $-94M | $22M | $-7M | $-2M | |
| Amort. of Intangibles | $91M | $82M | $85M | $77M | $49M | $15M | $18M | $21M | $31M | $32M | $17M | $18M | |
| Restructuring | · | · | · | · | · | · | · | $8M | $150M | · | · | · | |
| Other Non-cash | $-1.29B | $-890M | $316M | $-232M | $1.28B | $1.09B | $-448M | $-1.17B | $1.19B | $391M | $840M | $844M | |
| Operating Cash Flow | $-535M | $644M | $1.66B | $773M | $2.12B | $1.90B | $434M | $-314M | $804M | $673M | $1.12B | $1.06B | |
| CapEx | $101M | $100M | $84M | $91M | $77M | $74M | $57M | $30M | $86M | $176M | $132M | $115M | |
| Investing Cash Flow | $312M | $-464M | $-744M | $-790M | $-1.65B | $-400M | $-293M | $1.14B | $-1.06B | $-206M | $-1.42B | $-536M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $373M | $0 | |
| Stock Repurchased | $1.00B | $1.00B | $0 | $400M | $128M | $606M | $47M | $0 | $0 | · | $0 | $0 | |
| Net Stock Activity | $-1.00B | $-1.00B | $0 | $-400M | $-128M | $-606M | $-47M | · | $0 | $0 | $373M | $0 | |
| Financing Cash Flow | $-170M | $-347M | $-58M | $-441M | $-183M | $217M | $-559M | $-1.19B | $636M | $19M | $1.08B | $79M | |
| Net Change in Cash | $-393M | $-167M | $860M | $-458M | $283M | $1.72B | $-418M | $-364M | $378M | $486M | $790M | $603M | |
| Taxes Paid | $275M | $379M | $405M | $340M | $235M | $321M | $239M | $240M | $7M | $153M | $197M | $30M | |
| Free Cash Flow | $-636M | $544M | $1.58B | $682M | $2.04B | $1.82B | $370M | $-344M | $718M | $497M | · | · | |
| Levered FCF | · | · | $1.50B | $600M | $1.95B | $1.74B | $304M | $-425M | $619M | $471M | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 12.8% | 13.7% | 13.3% | 9.1% | 9.4% | 10.6% | · | |
| Operating Margin | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% | 5.5% | 6.2% | 6.0% | -2.8% | 1.7% | 2.7% | 2.0% | |
| Net Margin | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% | 4.4% | 3.7% | -2.6% | 0.29% | 1.0% | 0.64% | |
| Pretax Margin | 1.3% | 3.9% | 4.3% | 3.3% | 3.1% | 5.0% | 5.8% | 5.3% | -3.1% | 1.1% | 2.3% | 1.4% | |
| EBITDA Margin | 2.1% | 4.7% | 5.1% | 4.2% | 4.1% | 6.0% | 6.7% | 6.7% | -1.9% | 2.7% | 3.6% | 3.4% | |
| ROA | 3.0% | 7.7% | 8.0% | 6.5% | 6.1% | 8.2% | 10.6% | 9.0% | -6.4% | 0.74% | 2.6% | 1.7% | |
| ROE | 10.9% | 25.4% | 27.0% | 26.4% | 25.6% | 33.2% | 40.9% | 47.4% | -34.3% | 3.2% | 11.1% | 6.5% | |
| ROIC | 8.0% | 17.1% | 18.3% | 17.0% | 16.0% | 17.9% | 24.8% | 30.0% | -17.5% | 2.4% | 8.6% | 8.8% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 | 1.6 | 1.8 | 1.5 | 1.4 | 1.3 | 1.4 | 1.5 | |
| Quick Ratio | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 | 1.6 | 1.8 | 1.4 | 1.2 | 1.2 | 1.2 | 1.5 | |
| Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 1.0 | 0.3 | 0.0 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 0.7 | · | · | |
| Interest Coverage | · | · | 14.4 | 10.7 | 8.5 | 10.6 | 12.0 | 9.8 | -4.7 | 3.0 | 5.9 | 3.4 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.9 | 2.7 | 2.5 | 2.6 | 2.6 | 2.4 | 2.4 | 2.4 | 2.5 | 2.5 | 2.6 | 2.6 | |
| Receivables Turnover | 13.3 | 12.7 | 12.6 | 14.3 | 14.4 | 12.6 | 12.3 | 17.2 | 21.6 | 22.6 | 23.8 | 21.6 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $79.78 | $80.29 | $72.67 | $51.10 | · | $35.53 | $31.61 | $26.56 | $22.28 | $28.93 | $27.80 | $20.32 | |
| Revenue / Share | $858.71 | $704.51 | $586.44 | $546.56 | $473.91 | $323.72 | $262.95 | $283.63 | $355.05 | $317.54 | $253.18 | $199.97 | |
| Cash Flow / Share | $-10.11 | $11.16 | $28.61 | $13.21 | $36.16 | $31.50 | $6.67 | $-4.71 | $14.36 | $12.02 | $20.09 | $21.93 | |
| Cash / Share | $83.29 | $83.25 | $83.59 | $69.07 | · | $70.41 | $39.55 | $45.58 | $53.10 | $49.46 | $41.59 | $30.95 | |
| EPS (TTM) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 19.3% | 6.6% | 15.1% | 43.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.4% | 13.5% | 20.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -56.3% | 8.8% | 38.5% | 20.4% | 0.18% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -13.0% | 22.0% | 18.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -4.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -60.0% | 8.1% | 37.8% | 20.2% | -2.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.8% | 21.4% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.9% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Net Income TTM | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| Market Cap | $8.85B | $16.30B | $20.96B | $19.15B | · | $12.55B | $8.41B | $7.21B | $4.60B | $3.09B | $3.37B | $2.66B | |
| Enterprise Value | $4.36B | $10.23B | $14.03B | $13.82B | · | $8.65B | $5.25B | $3.72B | $209M | $161M | $-314M | $104M | |
| P/E | 19.5 | 14.3 | 19.2 | 24.4 | 28.3 | 18.9 | 11.8 | 11.0 | -8.5 | 59.0 | 23.3 | 41.5 | |
| P/S | 0.2 | 0.4 | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | |
| P/B | 2.2 | 3.6 | 5.0 | 6.5 | · | 6.0 | 4.3 | 4.4 | 3.4 | 1.9 | 2.2 | 2.6 | |
| P / Tangible Book | 4.7 | 6.4 | 7.6 | 12.2 | · | 10.9 | · | · | · | · | · | · | |
| P / Cash Flow | -16.5 | 25.3 | 12.6 | 24.8 | · | 6.6 | 19.7 | -22.9 | 5.7 | 4.6 | 3.0 | 2.5 | |
| P / FCF | -13.9 | 30.0 | 13.3 | 28.1 | · | 6.9 | 22.7 | -20.9 | 6.4 | 6.2 | · | · | |
| EV / EBITDA | 4.5 | 5.4 | 8.0 | 10.2 | · | 7.4 | 4.6 | 3.0 | -0.6 | 0.3 | -0.6 | 0.3 | |
| EV / FCF | -6.9 | 18.8 | 8.9 | 20.3 | · | 4.8 | 14.2 | -10.8 | 0.3 | 0.3 | · | · | |
| EV / Revenue | 0.1 | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.0 | 0.0 | -0.0 | 0.0 | |
| Earnings Yield | 5.1% | 7.0% | 5.2% | 4.1% | 3.5% | 5.3% | 8.5% | 9.1% | -11.8% | 1.7% | 4.3% | 2.4% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.87B | $10.80B | $11.38B | $11.48B | $11.43B | $11.15B | $10.50B | $10.34B | $9.88B | $9.93B | $9.05B | $8.55B | $8.33B | $8.15B | $8.22B | $7.93B | |
| Cost of Revenue | $9.44B | $9.27B | $10.14B | $10.04B | $9.83B | $9.48B | $9.00B | $8.64B | $8.37B | $8.41B | $7.45B | $7.31B | $7.04B | $6.87B | $6.99B | $6.75B | |
| SG&A Expense | $724M | $779M | $795M | $729M | $711M | $774M | $665M | $676M | $691M | $711M | $645M | $608M | $618M | $591M | $629M | $560M | |
| Operating Expenses | $10.73B | $10.71B | $11.54B | $11.34B | $11.05B | $10.71B | $10.12B | $9.87B | $9.45B | $9.51B | $8.73B | $8.19B | $7.88B | $7.69B | $8.12B | $7.59B | |
| Operating Income | $145M | $83M | $-162M | $137M | $373M | $433M | $380M | $467M | $434M | $426M | $316M | $359M | $443M | $455M | $105M | $335M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $27M | · | $27M | $27M | $28M | · | $28M | |
| Interest Income | · | · | · | · | · | · | · | $20M | $21M | $22M | · | $20M | $19M | $21M | · | $19M | |
| Other Non-op | · | · | · | · | · | · | · | · | $-28M | $-27M | · | $-27M | $-27M | $-28M | · | $-28M | |
| Pretax Income | $91M | $29M | $-214M | $88M | $325M | $390M | $346M | $438M | $406M | $399M | $289M | $332M | $416M | $427M | $78M | $307M | |
| Income Tax | $31M | $15M | $-54M | $9M | $70M | $92M | $95M | $112M | $105M | $98M | $73M | $87M | $107M | $106M | $22M | $77M | |
| Net Income | $60M | $14M | $-160M | $79M | $255M | $298M | $251M | $326M | $301M | $301M | $216M | $245M | $309M | $321M | $56M | $230M | |
| EPS (Basic) | $1.19 | $0.27 | $-2.80 | $1.51 | $4.75 | $5.47 | $4.46 | $5.67 | $5.18 | $5.21 | $3.72 | $4.24 | $5.37 | $5.58 | $0.98 | $4.00 | |
| EPS (Diluted) | $1.19 | $0.27 | $-2.79 | $1.51 | $4.75 | $5.45 | $4.43 | $5.65 | $5.17 | $5.17 | $3.69 | $4.21 | $5.35 | $5.52 | $0.96 | $3.95 | |
| Shares (Basic) | 51,100,000 | 50,900,000 | · | 52,500,000 | 53,600,000 | 54,600,000 | · | 57,600,000 | 58,100,000 | 57,900,000 | · | 57,800,000 | 57,700,000 | 57,500,000 | · | 57,600,000 | |
| Shares (Diluted) | 51,300,000 | 51,000,000 | · | 52,500,000 | 53,700,000 | 54,800,000 | · | 57,700,000 | 58,200,000 | 58,300,000 | · | 58,100,000 | 57,900,000 | 58,000,000 | · | 58,300,000 | |
| EBITDA | $145M | $122M | · | $137M | $373M | $481M | · | $467M | $434M | $471M | · | $359M | $443M | $499M | · | $335M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.99B | $5.31B | $4.25B | $4.22B | $4.50B | $4.86B | $4.66B | $4.73B | $4.35B | $4.51B | $4.85B | $5.57B | $4.91B | $4.55B | $4.01B | $4.24B | |
| Short-term Investments | $3.93B | $3.94B | $4.01B | $4.23B | $4.31B | $4.44B | $4.33B | $4.48B | $4.35B | $4.42B | · | $4.11B | $3.89B | $3.81B | · | $3.64B | |
| Receivables | $3.48B | $3.42B | $3.53B | $3.52B | $3.87B | $3.49B | $3.30B | $3.26B | $3.23B | $3.35B | · | $2.46B | $2.38B | $2.54B | · | $2.22B | |
| Prepaid Expense | $528M | $655M | $655M | $590M | $438M | $472M | $487M | $408M | $399M | $381M | · | $332M | $260M | $259M | · | $391M | |
| Current Assets | $12.93B | $13.33B | $12.44B | $12.55B | $13.11B | $13.26B | $12.77B | $12.88B | $12.33B | $12.67B | · | $12.47B | $11.44B | $11.16B | · | $10.49B | |
| PP&E (Gross) | · | · | $1.11B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $875M | · | · | · | $806M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | $1.96B | · | · | · | $1.67B | · | · | · | $1.24B | · | · | · | $1.11B | · | |
| Intangibles | · | · | $237M | · | · | · | $267M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $140M | $146M | $147M | $142M | $148M | $163M | $138M | $132M | $136M | $134M | · | $125M | $118M | $119M | · | $186M | |
| Total Assets | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Accounts Payable | $1.14B | $1.16B | $1.09B | $1.12B | $1.11B | $1.12B | $1.33B | $1.22B | $973M | $1.11B | · | $1.09B | $857M | $787M | · | $818M | |
| Current Liabilities | $7.70B | $8.19B | $7.37B | $7.48B | $7.88B | $8.15B | $7.90B | $8.34B | $7.84B | $8.51B | · | $8.49B | $7.54B | $7.61B | · | $7.24B | |
| Capital Leases | · | · | $56M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $179M | $176M | $173M | $174M | $167M | $155M | $120M | $122M | $122M | $124M | · | $121M | $122M | $88M | · | $118M | |
| Total Liabilities | $11.83B | $12.31B | $11.49B | $11.51B | $11.61B | $12.08B | $11.13B | $10.99B | $10.34B | $11.02B | · | $10.99B | $10.04B | $10.08B | · | $9.75B | |
| Total Debt | $3.77B | $3.77B | · | $3.66B | $3.38B | $3.57B | · | $2.33B | $2.18B | $2.18B | · | $2.18B | $2.18B | $2.18B | · | $2.17B | |
| Retained Earnings | $3.68B | $3.62B | $3.60B | $3.76B | $4.16B | $3.90B | $4.09B | $4.33B | $4.49B | $4.19B | · | $3.67B | $3.43B | $3.12B | · | $2.94B | |
| AOCI | $-16M | $-7M | $15M | $9M | $-10M | $-28M | $-57M | $-9M | $-85M | $-85M | · | $-165M | $-146M | $-125M | · | $-185M | |
| Stockholders' Equity | $4.17B | $4.08B | $4.07B | $4.19B | $4.60B | $4.31B | $4.50B | $4.77B | $4.84B | $4.49B | $4.21B | $3.88B | $3.62B | $3.29B | $2.96B | $3.04B | |
| Liabilities + Equity | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Shares Outstanding | 52,000,000 | 52,000,000 | 51,000,000 | 51,000,000 | 54,000,000 | 54,000,000 | 56,000,000 | 57,000,000 | 59,000,000 | 59,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $39M | $44M | $45M | $58M | $48M | $48M | $47M | $46M | $45M | $43M | $42M | $42M | $44M | $47M | $45M | |
| Stock-based Comp | $26M | $33M | $20M | $-3M | $3M | $27M | $18M | $30M | $32M | $36M | $27M | $33M | $30M | $25M | $23M | $23M | |
| Other Non-cash | · | $996M | · | · | · | $-183M | · | · | · | $-168M | · | · | · | $526M | · | · | |
| Operating Cash Flow | $-294M | $1.08B | $-298M | $-125M | $-302M | $190M | $-224M | $873M | $-219M | $214M | $-690M | $949M | $487M | $916M | $-212M | $254M | |
| CapEx | $30M | $27M | $-1M | $38M | $42M | $22M | $11M | $35M | $27M | $27M | $-5M | $26M | $31M | $32M | $10M | $31M | |
| Investing Cash Flow | $-30M | $11M | $230M | $77M | $128M | $-123M | $19M | $-48M | $53M | $-488M | $-25M | $-280M | $-137M | $-302M | $148M | $-347M | |
| Stock Repurchased | $0 | $0 | $0 | $500M | $0 | $500M | $500M | $500M | $0 | $0 | $0 | $0 | · | · | $200M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-500M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-4M | $-20M | $92M | $-220M | $-189M | $147M | $67M | $-364M | $12M | $-62M | $3M | $-6M | $10M | $-65M | $-183M | $10M | |
| Net Change in Cash | $-328M | $1.07B | $24M | $-268M | $-363M | $214M | $-138M | $461M | $-154M | $-336M | $-712M | $663M | $360M | $549M | $-247M | $-83M | |
| Free Cash Flow | · | $1.05B | · | · | · | $168M | · | · | · | $187M | · | · | · | $884M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $167M | · | · | · | $863M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 1.3% | 0.77% | · | 1.2% | 3.3% | 3.9% | · | 4.5% | 4.4% | 4.3% | · | 4.2% | 5.3% | 5.6% | · | 4.2% | |
| Net Margin | 0.55% | 0.13% | · | 0.69% | 2.2% | 2.7% | · | 3.1% | 3.0% | 3.0% | · | 2.9% | 3.7% | 3.9% | · | 2.9% | |
| Pretax Margin | 0.84% | 0.27% | · | 0.77% | 2.8% | 3.5% | · | 4.2% | 4.1% | 4.0% | · | 3.9% | 5.0% | 5.2% | · | 3.9% | |
| EBITDA Margin | 1.3% | 1.1% | · | 1.2% | 3.3% | 4.3% | · | 4.5% | 4.4% | 4.7% | · | 4.2% | 5.3% | 6.1% | · | 4.2% | |
| ROA | 0.37% | 0.09% | · | 0.50% | 1.6% | 1.9% | · | 2.1% | 2.1% | 2.1% | · | 1.8% | 2.4% | 2.5% | · | 1.9% | |
| ROE | 1.4% | 0.33% | · | 1.8% | 5.4% | 6.8% | · | 7.5% | 7.1% | 7.7% | · | 7.1% | 9.6% | 10.6% | · | 8.3% | |
| ROIC | 1.2% | 0.51% | · | 1.6% | 3.7% | 4.2% | · | 4.9% | 4.6% | 4.8% | · | 4.4% | 5.7% | 6.3% | · | 4.8% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.6 | · | 1.5 | 1.6 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.6 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 | |
| Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 15.8 | · | 13.3 | 16.4 | 16.2 | · | 12.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.7 | |
| Receivables Turnover | 3.0 | 3.1 | · | 3.4 | 3.2 | 3.3 | · | 3.6 | 3.5 | 3.4 | · | 3.7 | 3.6 | 3.5 | · | 3.8 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $80.21 | $78.46 | · | $82.18 | $85.24 | $79.81 | · | $83.68 | $82.08 | $76.15 | · | $66.88 | $62.43 | $56.69 | · | $52.43 | |
| Revenue / Share | $211.97 | $211.69 | · | $218.61 | $212.79 | $203.41 | · | $179.20 | $169.76 | $170.34 | · | $147.13 | $143.82 | $140.50 | · | $135.97 | |
| Cash Flow / Share | · | $21.22 | · | · | · | $3.47 | · | · | · | $3.67 | · | · | · | $15.79 | · | · | |
| Cash / Share | $95.87 | $102.19 | · | $82.76 | $83.31 | $89.93 | · | $83.02 | $73.80 | $76.49 | · | $95.95 | $84.66 | $78.52 | · | $73.14 | |
| EPS (TTM) | $0.18 | $3.74 | · | $16.14 | $20.28 | $20.70 | · | $19.68 | $18.24 | $18.42 | · | $16.04 | $15.78 | $14.68 | · | $14.33 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.52B | $45.08B | · | $44.55B | $43.41B | $41.87B | · | $39.20B | $37.41B | $35.85B | · | $33.25B | $32.63B | $32.35B | · | $31.16B | |
| Net Income TTM | $-7M | $188M | · | $883M | $1.13B | $1.18B | · | $1.14B | $1.06B | $1.07B | · | $931M | $916M | $855M | · | $839M | |
| Market Cap | $11.89B | $6.93B | · | $9.76B | $16.09B | $17.79B | · | $19.64B | $17.54B | $24.24B | · | $19.02B | $17.47B | $15.51B | · | $19.13B | |
| Enterprise Value | $6.75B | $1.45B | · | $4.98B | $10.65B | $12.07B | · | $12.76B | $11.02B | $17.48B | · | $11.52B | $10.85B | $9.33B | · | $13.42B | |
| P/E | 1270.6 | 35.6 | · | 11.9 | 14.7 | 15.9 | · | 17.5 | 16.3 | 22.3 | · | 20.4 | 19.1 | 18.2 | · | 23.0 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | |
| P/B | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Tangible Book | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Cash Flow | · | 6.4 | · | · | · | 93.6 | · | · | · | 113.3 | · | · | · | 16.9 | · | · | |
| EV / Revenue | 0.2 | 0.0 | · | 0.1 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| Earnings Yield | 0.08% | 2.8% | · | 8.4% | 6.8% | 6.3% | · | 5.7% | 6.1% | 4.5% | · | 4.9% | 5.2% | 5.5% | · | 4.3% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B |
| Faaliyet Kâr Marjı % | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% |
| Net Gelir | $472M | $1.18B | $1.09B | $792M | $659M |
| Seyreltilmiş Hisse Başı Kâr | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 |
| Cari Oran | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 |
| Cari Oran | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-636M | $544M | $1.58B | $682M | $2.04B |
Kurumsal Sahipler (13F) 675 dosya · $13.8B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 159 (+18 önceki Ç'ye göre) | 68 (-75 önceki Ç'ye göre) | 219 (+23 önceki Ç'ye göre) | 181 (+8 önceki Ç'ye göre) | +1.1M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $1.503.052.088 | 6.572.156 | 10,91% | Hisse senetleri |
| VANGUARD GROUP INC | $1.055.736.837 | 6.083.536 | 7,66% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $806.903.452 | 3.560.601 | 5,86% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $638.128.574 | 2.790.243 | 4,63% | Hisse senetleri |
| Capital World Investors | $586.138.203 | 2.562.913 | 4,26% | Hisse senetleri |
| Lingotto Investment Management LLP | $574.377.763 | 2.511.490 | 4,17% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $538.648.191 | 2.355.261 | 3,91% | Hisse senetleri |
| FMR LLC | $427.964.063 | 1.871.290 | 3,11% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $427.014.918 | 1.867.140 | 3,10% | Hisse senetleri |
| STATE STREET CORP | $401.475.303 | 1.755.467 | 2,91% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $318.659.985 | 1.393.338 | 2,31% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $298.810.862 | 1.306.563 | 2,17% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $289.810.242 | 1.267.207 | 2,10% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $289.611.501 | 1.266.338 | 2,10% | Hisse senetleri |
| Capital Research Global Investors | $249.797.804 | 1.092.251 | 1,81% | Hisse senetleri |
| MORGAN STANLEY | $230.316.927 | 1.007.068 | 1,67% | Hisse senetleri |
| HARRIS ASSOCIATES L P | $218.980.250 | 957.500 | 1,59% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $204.005.369 | 891.772 | 1,48% | Hisse senetleri |
| 8 KNOTS MANAGEMENT, LLC | $198.942.438 | 1.146.378 | 1,44% | Hisse senetleri |
| MANNING & NAPIER ADVISORS LLC | $152.338.582 | 663.669 | 1,11% | Hisse senetleri |
| UBS Group AG | $142.749.967 | 624.180 | 1,04% | Hisse senetleri |
| Long Focus Capital Management, LLC | $139.507.000 | 610.000 | 1,01% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $131.512.792 | 575.045 | 0,95% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $116.582.437 | 671.790 | 0,85% | Hisse senetleri |
| Invesco Ltd. | $116.332.600 | 508.669 | 0,84% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $115.548.617 | 505.241 | 0,84% | Hisse senetleri |
| NORTHERN TRUST CORP | $88.292.838 | 386.064 | 0,64% | Hisse senetleri |
| NORGES BANK | $87.054.426 | 380.649 | 0,63% | Hisse senetleri |
| Bank of New York Mellon Corp | $86.138.019 | 376.642 | 0,63% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $82.789.400 | 362.000 | 0,60% | Satım opsiyonu |
| BNP PARIBAS FINANCIAL MARKETS | $82.559.556 | 360.995 | 0,60% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $75.497.758 | 330.117 | 0,55% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $72.051.935 | 315.050 | 0,52% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $71.479.956 | 312.549 | 0,52% | Hisse senetleri |
| Amundi | $59.944.786 | 262.111 | 0,44% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $57.795.692 | 252.714 | 0,42% | Hisse senetleri |
| Maple Rock Capital Partners Inc. | $55.642.710 | 243.300 | 0,40% | Hisse senetleri |
| Russell Investments Group, Ltd. | $53.133.740 | 232.165 | 0,39% | Hisse senetleri |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | $52.660.005 | 230.258 | 0,38% | Hisse senetleri |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $51.238.863 | 224.044 | 0,37% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $47.575.775 | 208.027 | 0,35% | Hisse senetleri |
| CITIGROUP INC | $47.390.070 | 207.215 | 0,34% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46.357.490 | 202.700 | 0,34% | Alım opsiyonu |
| REDWOOD CAPITAL MANAGEMENT, LLC | $45.740.000 | 200.000 | 0,33% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $45.272.766 | 197.957 | 0,33% | Hisse senetleri |
| INVESTMENT HOUSE LLC | $44.310.854 | 193.751 | 0,32% | Hisse senetleri |
| JANE STREET GROUP, LLC | $43.224.300 | 189.000 | 0,31% | Satım opsiyonu |
| Fiera Capital Corp | $43.130.075 | 188.588 | 0,31% | Hisse senetleri |
| Summit Street Capital Management, LLC | $41.630.489 | 182.031 | 0,30% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $41.211.511 | 180.199 | 0,30% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Mary R. Molina Living Trust, Exempt Mary R. Molina Living Trust, Mary R. Molina Grantor Retained Annuity Trust 609/4, Mary R. Molina Grantor Retained Annuity Trust 609/7, Mary R. Molina Grantor Retained Annuity Trust 1209/3, Mary R. Molina Grantor Retained Annuity Trust 1209/4, Mary R. Molina Grantor Retained Annuity Trust 610/4, Mary R. Molina Grantor Retained Annuity Trust 610/5, Mary R. Molina Grantor Retained Annuity Trust 1210/4, Mary R. Molina Grantor Retained Annuity Trust 811/3, Mary R. Molina Grantor Retained Annuity Trust 812/3, Estate of Mary R. Molina, Dentino Family Trust, Curtis and Rosi Pedersen 2012 Trust, William Dentino, Curtis Pedersen ×3 başvurular | 23 Ocak 2018 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 62 içeriden öğrenenler · 25 yöneticiler · 19 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Roman Kulich | Pres & CEO of Molina of MI | 22 Ağustos 2007 S | 5.734 | 0 | 0 | $0 |
| Gerald Landgraf | CEO/Pres of Molina of NM | 01 Temmuz 2005 A | · | 0 | 0 | $0 |
| Mark Lowell Keim | Chief Financial Officer | 01 Mart 2026 A | 83.251 | 0 | 0 | $0 |
| Joseph W White CPA | Former Chief Financial Officer | 06 Haziran 2018 D | 48.390 | 0 | 0 | $0 |
| James Woys | Chief Operating Officer | 30 Haziran 2026 A | 90.178 | 0 | 0 | $0 |
| Terry Bayer | Chief Operating Officer | 02 Şubat 2018 D | 28.730 | 0 | 0 | $0 |
| Debra Bacon | EVP, Medicaid | 01 Temmuz 2026 F | 21.636 | 0 | 0 | $0 |
| Jeff D. Barlow | Chief Legal Officer | 30 Haziran 2026 A | 67.313 | 0 | 1 | $-3.314.983 |
| Marc Russo | EVP, Health Plans | 07 Ağustos 2023 S | 37.093 | 0 | 0 | $0 |
| Pamela Sedmak | Executive Vice President | 01 Mart 2020 F | 8.846 | 0 | 0 | $0 |
| Lisa A Rubino | Senior Vice President | 01 Mart 2018 F | 25.084 | 0 | 0 | $0 |
| Keith Wilson | Chief Medical Officer | 30 Haziran 2017 A | 29.441 | 0 | 0 | $0 |
| Amir Desai | Chief Information Officer | 16 Ağustos 2010 S | 16.782 | 0 | 0 | $0 |
| Mark L Andrews ESQ | Exec. VP, General Counsel | 01 Temmuz 2010 F | 51.006 | 0 | 0 | $0 |
| Mary Martha Bernadett MD | Exec. V.P., Research | 05 Aralık 2008 J | 50.000 | 0 | 0 | $0 |
| Stephen T O'Dell | Regional Vice President | 07 Ağustos 2008 F | 16.199 | 0 | 0 | $0 |
| Lillis Ann Koontz | Regional Vice President | 30 Haziran 2008 A | 15.304 | 0 | 0 | $0 |
| George Kirk Olsen | VP, Molina Advantage | 29 Haziran 2007 A | 7.822 | 0 | 0 | $0 |
| Michael M Siegel | Chief Medical Officer | 01 Mart 2007 A | 5.150 | 0 | 0 | $0 |
| Rick Click | Chief Information Officer | 01 Mart 2007 A | 8.500 | 0 | 0 | $0 |
| Harvey A Fein | VP, Internal Auditing | 01 Mart 2007 A | 8.713 | 0 | 0 | $0 |
| Joann Zarza-Garrido | VP, Compliance | 28 Şubat 2007 S | 4.774 | 0 | 0 | $0 |
| William Bracciodieta | Former Chief Medical Officer | 16 Şubat 2007 F | 5.000 | 0 | 0 | $0 |
| Sheila Shapiro | Exec. VP, Shared Services | 30 Aralık 2005 J | 12.564 | 0 | 0 | $0 |
| Jennings Patricia Dinsmore | VP Qual. Op. & Integration | 16 Ağustos 2004 S | 0 | 0 | 0 | $0 |
| Stephen H Lockhart | Yönetim kurulu üyesi | 01 Ekim 2026 A | 4.688 | 0 | 0 | $0 |
| Richard M Schapiro | Yönetim kurulu üyesi | 01 Ekim 2026 A | 12.615 | 0 | 1 | $-51.058 |
| Richard C Zoretic | Yönetim kurulu üyesi | 01 Ekim 2026 A | 9.693 | 1 | 0 | $100.128 |
| Leo P Grohowski | Yönetim kurulu üyesi | 01 Ekim 2026 A | 1.846 | 0 | 0 | $0 |
| Francis S Soistman JR | Yönetim kurulu üyesi | 01 Ekim 2026 A | 1.211 | 0 | 0 | $0 |
| Dale B Wolf | Yönetim kurulu üyesi | 01 Ekim 2026 A | 15.937 | 0 | 0 | $0 |
| Steven J Orlando | Yönetim kurulu üyesi | 01 Ekim 2026 A | 18.271 | 0 | 0 | $0 |
| Ronna Romney | Yönetim kurulu üyesi | 01 Ekim 2026 A | 18.173 | 0 | 1 | $-74.342 |
| Barbara L Brasier | Yönetim kurulu üyesi | 01 Ekim 2026 A | 6.122 | 0 | 0 | $0 |
| Daniel Cooperman | Yönetim kurulu üyesi | 01 Nisan 2025 A | 6.383 | 0 | 0 | $0 |
| Garrey Carruthers | Yönetim kurulu üyesi | 01 Nisan 2021 A | 5.265 | 0 | 0 | $0 |
| Charles Z Fedak | Yönetim kurulu üyesi | 01 Nisan 2019 A | 19.092 | 0 | 0 | $0 |
| John C Molina | Yönetim kurulu üyesi | 20 Şubat 2018 S | 372.930 | 0 | 0 | $0 |
| Frank E Murray MD | Yönetim kurulu üyesi | 01 Ekim 2017 A | 16.811 | 0 | 0 | $0 |
| Steven James | Yönetim kurulu üyesi | 01 Nisan 2016 A | 15.024 | 0 | 0 | $0 |
| John P Szabo JR | Yönetim kurulu üyesi | 01 Nisan 2015 A | 17.097 | 0 | 0 | $0 |
| Sally K Richardson | Yönetim kurulu üyesi | 03 Mayıs 2012 A | 47.537 | 0 | 0 | $0 |
| Wayne B Lowell | Yönetim kurulu üyesi | 10 Mayıs 2007 A | 10.011 | 0 | 0 | $0 |
| Ronald Cpa Dba Lossett | Yönetim kurulu üyesi | 10 Şubat 2004 A | · | 0 | 0 | $0 |
| MARY R MOLINA LIVING TRUST | 10% sahip | 14 Aralık 2009 J | 2.137.134 | 0 | 0 | $0 |
| MOLINA MARITAL TRUST | 10% sahip | 22 Haziran 2006 S | 2.926.907 | 0 | 0 | $0 |
| Maurice Hebert | · | 14 Mayıs 2026 S | 12.815 | 0 | 1 | $-114.930 |
| Joseph M Zubretsky | · | 01 Mart 2026 A | 99.015 | 0 | 0 | $0 |
| Thomas L Tran | · | 24 Mayıs 2021 F | 29.775 | 0 | 0 | $0 |
| Norman Nichols | · | 08 Ağustos 2018 S | 47.415 | 0 | 0 | $0 |
| Harold Gooch | · | 30 Haziran 2018 A | 7.063 | 0 | 0 | $0 |
| Mario J Molina MD | · | 11 Aralık 2017 S | 61.125 | 0 | 0 | $0 |
| James W Howatt | · | 19 Mart 2010 S | 34.081 | 0 | 0 | $0 |
| Curtis Pedersen | · | 05 Kasım 2009 G | 1.200 | 0 | 0 | $0 |
| Josephine M Molina | · | 06 Ağustos 2008 J | 345.701 | 0 | 0 | $0 |
| Janet M Watt | · | 06 Ağustos 2008 J | 284.641 | 0 | 0 | $0 |
| Josephine M Battiste | · | 06 Ağustos 2008 J | 345.701 | 0 | 0 | $0 |
| Zarina Sparling | · | 21 Şubat 2008 M | 9.380 | 0 | 0 | $0 |
| Mary R Molina | · | 27 Eylül 2006 J | 0 | 0 | 0 | $0 |
| George S Goldstein PHD | · | 11 Mayıs 2006 M | 0 | 0 | 0 | $0 |
| Richard A Helmer MD | · | 30 Haziran 2005 J | 1.908 | 0 | 0 | $0 |
| David W Erickson | · | 02 Aralık 2004 M | 0 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 73 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| SOVF · Elevation Series Trust | 4,23% | 18.894 NS | 31 Temmuz 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 1,81% | 120.017 SH | 01 Ekim 2026 | Günlük |
| RFV · Invesco Exchange-Traded Fund Trust | 1,77% | 29.907 SH | 01 Ekim 2026 | Günlük |
| IHF · iShares Trust | 1,53% | 100.080 SH | 11 Eylül 2026 | Günlük |
| VIOV · VANGUARD ADMIRAL FUNDS | 1,28% | 110.553 SH | 19 Ağustos 2026 | Günlük |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,76% | 5.983.000 | 01 Ekim 2026 | Günlük |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,64% | 182.154 SH | 19 Ağustos 2026 | Günlük |
| FFLV · FIDELITY COVINGTON TRUST | 0,41% | 343 NS | 31 Temmuz 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,40% | 6.790 NS | 31 Temmuz 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,33% | 7.103 SH | 01 Ekim 2026 | Günlük |
| DFAT · Dimensional ETF Trust | 0,27% | 198.247 NS | 31 Temmuz 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,26% | 8.610 NS | 31 Temmuz 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,25% | 758.589 SH | 19 Ağustos 2026 | Günlük |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 22.626 NS | 31 Temmuz 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,22% | 765 NS | 31 Temmuz 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,20% | 3.918 NS | 31 Temmuz 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,18% | 156.577 SH | 19 Ağustos 2026 | Günlük |
| ESML · iShares Trust | 0,17% | 23.899 SH | 11 Eylül 2026 | Günlük |
| IYH · iShares Trust | 0,17% | 30.059 SH | 11 Eylül 2026 | Günlük |
| DFSV · Dimensional ETF Trust | 0,16% | 67.624 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,16% | 7.446 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,15% | 24.870 NS | 31 Temmuz 2026 | N-PORT |
| SMMD · iShares Trust | 0,14% | 27.458 SH | 11 Eylül 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,14% | 1.195.007 SH | 19 Ağustos 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,13% | 597.850 SH | 19 Ağustos 2026 | Günlük |
| IWS · iShares Trust | 0,10% | 77.233 SH | 11 Eylül 2026 | Günlük |
| WSML · iShares Trust | 0,10% | 3.305 SH | 11 Eylül 2026 | Günlük |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,10% | 4.920 SH | 01 Ekim 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 3.768 SH | 01 Ekim 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,09% | 68.863 NS | 31 Temmuz 2026 | N-PORT |
| IWR · iShares Trust | 0,08% | 210.604 SH | 11 Eylül 2026 | Günlük |
| PRF · Invesco Exchange-Traded Fund Trust | 0,07% | 35.013 SH | 01 Ekim 2026 | Günlük |
| EMGF · iShares, Inc. | 0,06% | 15.805 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,05% | 1.409 NS | 31 Temmuz 2026 | N-PORT |
| EMXC · iShares, Inc. | 0,05% | 162.911 SH | 11 Eylül 2026 | Günlük |
| DFSU · Dimensional ETF Trust | 0,04% | 5.157 NS | 31 Temmuz 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,03% | 305 NS | 31 Temmuz 2026 | N-PORT |
| IUSV · iShares Trust | 0,03% | 45.470 SH | 11 Eylül 2026 | Günlük |
| IEMG · iShares, Inc. | 0,03% | 689.771 SH | 11 Eylül 2026 | Günlük |
| EEM · iShares, Inc. | 0,03% | 131.827 SH | 11 Eylül 2026 | Günlük |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 31.058 SH | 19 Ağustos 2026 | Günlük |
| IWD · iShares Trust | 0,03% | 114.206 SH | 11 Eylül 2026 | Günlük |
| DFUV · Dimensional ETF Trust | 0,03% | 20.443 NS | 31 Temmuz 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,03% | 52.472 SH | 11 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,02% | 2.686 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 1.655.258 SH | 19 Ağustos 2026 | Günlük |
| VWO · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 868.836 SH | 19 Ağustos 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 8.548 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 4.354 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,02% | 11.634 SH | 19 Ağustos 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,02% | 45.023 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 2.946 NS | 31 Temmuz 2026 | N-PORT |
| IXUS · iShares Trust | 0,02% | 126.782 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,01% | 14.718 SH | 11 Eylül 2026 | Günlük |
| IWB · iShares Trust | 0,01% | 35.396 SH | 11 Eylül 2026 | Günlük |
| IYY · iShares Trust | 0,01% | 2.168 SH | 11 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,01% | 15.184 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 67.059 SH | 11 Eylül 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,01% | 8.285 NS | 31 Temmuz 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0,01% | 531.000 SH | 11 Eylül 2026 | Günlük |
| VOXP · Advisors Series Trust | 0,01% | 3 NS | 31 Temmuz 2026 | N-PORT |
| ACWX · iShares Trust | 0,01% | 16.724 SH | 11 Eylül 2026 | Günlük |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 910.737 SH | 19 Ağustos 2026 | Günlük |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 145.760 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 89.282 SH | 19 Ağustos 2026 | Günlük |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,01% | 68.906 SH | 19 Ağustos 2026 | Günlük |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.303 SH | 01 Ekim 2026 | Günlük |
| ACWI · iShares Trust | 0,00% | 8.307 SH | 11 Eylül 2026 | Günlük |
| IJH · iShares Trust | · | 1.828.162 SH | 11 Eylül 2026 | Günlük |
| IJJ · iShares Trust | · | 265.658 SH | 21 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 2.352 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 6.481 SH | 11 Eylül 2026 | Günlük |
| SMMV · iShares Trust | · | 4.872 SH | 01 Eylül 2026 | Günlük |
MOH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
12 Aylık Fiyat Hedefi
17 analist · 2026-09-30Ortalama hedef $209.12 +10,3%
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.